Pinsent Masons advises IP Group on fund raising and acquisition of Fusion IP

28 Jan 2014 | 04:36 pm |

International law firm Pinsent Masons has advised IP Group on its proposed acquisition by way of a scheme of arrangement of investment business Fusion IP at a price of more than £85 million.

Corporate partner Russell Booker led a team advising the IP commercialisation business on the deal which was announced at the same as a £75 million fund raising and open offer of 45.5 million shares to raise up to £75m by way of a firm placing, open offer and placing.

Commenting on the deal, Russell Booker, said: "The fund raising and acquisition is transformational for both companies providing broader capabilities across the UK. Fusion and IP Group are both innovative in the field of intellectual property and provide essential research across a number of areas.

The deal clearly highlights Pinsent Masons' expertise across the IP and life sciences industry as well as its corporate capabilities."

IP Group, which acquired 20.1 per cent of Fusion in 2009, works with 11 universities in the UK supporting IP development in fields as diverse as computer-aided drug discovery to fuel cell technology and graphene. Fusion currently works with four universities.

The capital raising will enable IP Group to accelerate growth across a number of sectors pursue, novel therapeutics and consider future spin-out companies.

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises GNA Biosolutions GmbH on Covid-19 rapid PCR test

Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.

Pinsent Masons advises ALK Capital on its acquisition of Burnley FC

Multinational law firm Pinsent Masons has advised ALK Capital on the acquisition of Burnley Football Club.

Pinsent Masons advises Unbound on financing in fitness start-up VAHA

Pinsent Masons has advised Unbound on its investment in etone Motion Analysis GmbH (VAHA), a manufacturer of smart digital mirrors.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts